Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical instruments specialist Harvard Bioscience (Nasdaq: HBIO ) has earned a coveted five-star ranking.
With that in mind, let's take a closer look at Harvard Bioscience's business and see what CAPS investors are saying about the stock right now.
Harvard Bioscience facts
|
Headquarters (Founded)
|
Holliston, Mass. (1901)
|
|
Market Cap
|
$168.6 million
|
|
Industry
|
Life sciences tools and services
|
|
Trailing-12-Month Revenue
|
$108.2 million
|
|
Management
|
Chairman/CEO Chane Graziano
CFO Thomas McNaughton
|
|
Return on Equity (Average, Past 3 Years)
|
13.6%
|
|
Cash/Debt
|
$19.7 million / $18 million
|
|
Competitors
|
Becton Dickinson (NYSE: BDX )
Bio-Rad Laboratories (NYSE: BIO )
Thermo Fisher Scientific (NYSE: TMO )
|
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
On CAPS, 96% of the 143 members who have rated Harvard Bioscience so far believe the stock will outperform the S&P 500 going forward. These bulls include Notwage and All-Star JakilaTheHun, who is ranked in the top 0.1% of our community.
Earlier this month , Notwage listed several of Harvard Bioscience's positives:
"Rock solid fundamentals. Great industry with bright growth prospects in healthcare. Great margin of safety. Not covered by analysts. All in all a solid growth pick on sale."
Over the next five years, in fact, Harvard Bioscience is expected to grow its bottom line at a brisk rate of 25% annually. That's much faster than listed rivals Becton (9.9%), Bio-Rad (9.5%), and Thermo Fisher (12.1%).
CAPS All-Star JakilaTheHun elaborates on the Harvard Bioscience bull case:
Very well-run company, with great management, and an excellent track record of success. ROI is at 18% and ROE is at 23%. ... Not "cheap" per se, but about fairly valued right now. I can't claim to know much about this industry, but my green thumb for this one is a bet of management continuing to earn above-market returns on their investments.
What do you think about Harvard Bioscience -- or any other stock, for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!
RSS Headlines
Fool UK